dermatology

GLP-1 RAs Provide Greater Hepatic Benefit Than SGLT2is For MASLD, Type 2 Diabetes

by

The Evolving Landscape of Liver Disease Treatment: GLP-1 Receptor Agonists vs. SGLT2 Inhibitors Recent studies have spotlighted the effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) over sodium-glucose cotransporter-2 inhibitors (SGLT2i) in managing liver conditions associated with type 2 diabetes (T2D). This breakthrough has potential ramifications for the future of liver disease treatment, particularly for … Read more

‘Ozempic face’ and Baby Boomers drive injectables craze

by

The Future of Neuromodulators and Fillers The aesthetic medicine industry is witnessing rapid advancements, particularly in the market for neuromodulators and fillers. As a key player, Galderma competes closely with AbbVie, making the space both dynamic and innovative. Here’s a look at the trends shaping the future of this multi-billion-dollar industry. Emerging Demand from Weight … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]